What the public record shows — the first real index

Litmus now tracks 71 real, named peptide vendors. Every signal on a vendor page is a public, sourced fact or an honest "insufficient" — nothing is invented.

The headline finding: 47 of 71 vendors sell approved prescription-only medicines (semaglutide, tirzepatide and others) to the public with no prescription, under a "research use only" disclaimer — buying a prescription medicine with no prescription bypasses medical supervision.

What else the records show today. Domain registration dates resolved for 56 of 71 vendors via ICANN RDAP, of which 19 hold a domain less than a year old — the new-domain signal nobody else surfaces. 5 vendors map to a single confirmed active UK company on the Companies House register; the rest show "not found", which is neutral, not a mark against them. 61 of 71 sites were reachable for a transparency crawl scored from each vendor's own pages, quote and URL attached.

What we do not yet claim. We do not generate lab data and do not scrape independent assays, so Lab Reliability shows "insufficient" for every vendor. Community sentiment sources block unauthenticated access, so Verified Experience is also "insufficient" until an authenticated review source is wired. Because of that, no vendor carries an overall trust score yet — public-record facts alone don't establish trust, and we won't pretend otherwise.

Right of reply. Any vendor can contest a fact. Every figure links to its source; corrections are logged openly.